A new study warns that relying on clinical symptoms of memory loss to diagnose Alzheimer’s disease may miss other forms of dementia that do not initially affect memory.
Northwestern Medicine researchers discovered people who present with atypical forms of Alzheimer’s often miss out on opportunities to participate in clinical trials to treat Alzheimer’s.
There is more than one kind of Alzheimer’s disease. Alzheimer’s can cause language problems, disrupt an individual’s behavior, personality, and judgment or even affect someone’s concept of where objects are in space.
If it affects personality, it may cause lack of inhibition. “Someone who was very shy may go up to grocery store clerk — who is a stranger — and try to give her a hug or kiss,” said first author Dr. Emily Rogalski, associate professor at Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center.
Researchers say the presence or absence of memory loss all depends on what part of the brain is affected. A definitive diagnosis can only be achieved with an autopsy.
Emerging evidence suggests an amyloid PET scan, an imaging test that tracks the presence of amyloid — an abnormal protein whose accumulation in the brain is a hallmark of Alzheimer’s — may be used during life to determine the likelihood of Alzheimer’s disease pathology.
In the study, the authors identify the clinical features of individuals with primary progressive aphasia (PPA), a rare dementia that causes progressive declines in language abilities due to Alzheimer’s disease. Early on in PPA, memory, and other thinking abilities are relatively intact.
PPA can be caused either by Alzheimer’s disease or another neurodegenerative disease family called frontotemporal lobar degeneration.
The presence of Alzheimer’s disease was assessed in this study by amyloid PET imaging or confirmed by autopsy.
The study demonstrates that knowing an individual’s clinical symptoms isn’t sufficient to determine whether someone has PPA due to Alzheimer’s disease or another type of neurodegenerative disease.
Because of this, biomarkers, such as amyloid PET imaging, are necessary to identify the neuropathological cause, the authors said.
In the study, Northwestern scientists looked at individuals in mild stages of language loss caused by Alzheimer’s disease and described their brain atrophy based on MRI scans and their results on cognitive tests.
“We wanted to describe these individuals to raise awareness about the early clinical and brain features of PPA to develop metrics which would advocate for their inclusion in clinical trials targeting Alzheimer’s disease,” Rogalski said.
“These individuals are often excluded because they don’t have memory deficits, but they share the same disease [Alzheimer’s] that’s causing their symptoms.”
Related Online Continuing Education Courses
 |
This course is presented in two parts. Part 1 offers strategies for managing the everyday challenges of caring for a person with Alzheimer’s disease, a difficult task that can quickly become overwhelming. Research has shown that caregivers themselves often are at increased risk for depression and illness. Each day brings new challenges as the caregiver copes with changing levels of ability and new patterns of behavior. Many caregivers have found it helpful to use the strategies described in this course for dealing with difficult behaviors and stressful situations.Part 2 includes tips on acute hospitalization, which presents a new environment filled with strange sights, odors and sounds, changes in daily routines, along with new medications and tests. This section is intended to help professionals and family members meet the needs of hospitalized Alzheimer’s patients by offering facts about Alzheimer’s disease, communication tips, personal care techniques, and suggestions for working with behaviors and environmental factors in both the ER and in the hospital room.
|
 |
A diagnosis of dementia can be frightening for those affected by the syndrome, their family members, and caretakers. Learning more about dementia can help. This course provides a general overview of dementia and specific types of dementia along with their signs and symptoms; lists risk factors that can increase a person’s chance of developing one or more kinds of dementia; describes how the disorders are diagnosed and treated, including drug therapy; and offers highlights of research that is supported by the National Institute of Neurological Disorders and Stroke and the National Institute on Aging, both part of the National Institutes of Health (NIH).
|
 |
Alzheimer’s – Unraveling the Mystery is a 3-hour online continuing education (CE/CEU) course that describes the risk factors, effective steps for prevention, strategies for diagnosing and treating, and the search for new treatments for AD. Alzheimer’s dementia is a growing concern among the aging Baby Boomers; yet, modern science points the way to reducing the risks through maintaining a healthy lifestyle. This course is based on a publication from the National Institute on Aging, which describes healthy brain functioning during the aging process and then contrasts it to the processes of Alzheimer’s disease. Strategies for reducing caregiver stress are also briefly discussed.
|
 |
What is aging? Can we live long and live well—and are they the same thing? Is aging in our genes? How does our metabolism relate to aging? Can your immune system still defend you as you age? Since the National Institute on Aging was established in 1974, scientists asking just such questions have learned a great deal about the processes associated with the biology of aging. Technology today supports research that years ago would have seemed possible only in a science fiction novel. This course introduces some key areas of research into the biology of aging. Each area is a part of a larger field of scientific inquiry. You can look at each topic individually, or you can step back to see how they fit together, interwoven to help us better understand aging processes. Research on aging is dynamic, constantly evolving based on new discoveries, and so this course also looks ahead to the future, as today’s research provides the strongest hints of things to come.
|
Professional Development Resources, Inc. is a Florida nonprofit educational corporation 501(c)(3) that offers 150+ online, video and book-based continuing education courses for healthcare professionals. We are approved by the American Psychological Association (APA); the National Board of Certified Counselors (NBCC); the Association of Social Work Boards (ASWB); the American Occupational Therapy Association (AOTA); the American Speech-Language-Hearing Association (ASHA); the Commission on Dietetic Registration (b); the Alabama State Board of Occupational Therapy; the Florida Boards of Social Work, Mental Health Counseling and Marriage and Family Therapy, Psychology & School Psychology, Dietetics & Nutrition, Speech-Language Pathology and Audiology, and Occupational Therapy Practice; the Ohio Counselor, Social Worker & MFT Board and Board of Speech-Language Pathology and Audiology; the South Carolina Board of Professional Counselors & MFTs; and by the Texas Board of Examiners of Marriage & Family Therapists and State Board of Social Worker Examiners. |
